When.com Web Search

  1. Ads

    related to: fda approved screening products for osteoporosis vaccine near me

Search results

  1. Results From The WOW.Com Content Network
  2. Tecovirimat - Wikipedia

    en.wikipedia.org/wiki/Tecovirimat

    [4] [7] [8] In 2018 it was the first antipoxviral drug approved in the United States. The drug works by blocking cellular transmission of orthopoxviruses, thus preventing disease. [9] Tecovirimat has been effective in laboratory testing; it has been shown to protect animals from mpox and rabbitpox and causes no serious side effects in humans. [6]

  3. Life Line Screening - Wikipedia

    en.wikipedia.org/wiki/Life_Line_Screening

    In April 2013, the Journal of the American College of Cardiology published a study that relied on Life Line Screening data from a population-based screening study of more than 3.6 million Americans. Results showed the prevalence of peripheral artery disease (PAD) increased from 1 in 50 in the 40-to-50-year-old age group, to nearly 1 in 3 in the ...

  4. Ibandronic acid - Wikipedia

    en.wikipedia.org/wiki/Ibandronic_acid

    In May 2003, the US Food and Drug Administration (FDA) approved ibandronate as a daily treatment for post-menopausal osteoporosis. [medical citation needed] The basis for this approval was a three-year, randomized, double-blind, placebo-controlled trial women with post-menopausal osteoporosis.

  5. U.S. Food And Drug Administration (FDA) Accepts New Drug ...

    www.aol.com/news/2012-12-13-us-food-and-drug...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Emergent Bio's smallpox vaccine gets US approval for mpox - AOL

    www.aol.com/news/us-fda-approves-emergents...

    (Reuters) -The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' smallpox vaccine for use in people at high risk of mpox infection. The FDA clearance, announced ...

  7. Teriparatide - Wikipedia

    en.wikipedia.org/wiki/Teriparatide

    These characteristics allowed the product to be approved under a 505(b)(2) NDA for which Forteo was the reference drug. It may provide a lower-cost teriparatide option for increasing bone density in patients at high risk for fracture, and is FDA-approved for the same indications as Forteo, which means it can be used for the same patients as ...